Literature DB >> 28597072

Normal and altered pre-mRNA processing in the DMD gene.

Sylvie Tuffery-Giraud1, Julie Miro2, Michel Koenig2,3, Mireille Claustres2,3.   

Abstract

Splicing of pre-mRNA is a crucial regulatory stage in the pathway of gene expression controlled by multiple post- and co-transcriptional mechanisms. The large Duchenne muscular dystrophy gene encoding the protein dystrophin provides a striking example of the complexity of human pre-mRNAs. In this review, we summarize the current state of knowledge about canonical and non-canonical splicing in the DMD pre-mRNA, with a focus on mechanisms that take place in the full-length transcript isoform expressed in human skeletal muscle. In particular, we highlight recent work demonstrating that multi-step events are required for long DMD intron removal. The role of temporary intron retention in the occurrence of alternative splicing events is also discussed. Even though the proportion of splicing mutations is lower than reported in other genes, a great diversity of splicing defects linked to point mutations, but also large genomic rearrangements are observed in the DMD gene. We provide an overview of the molecular mechanisms underlying aberrant splicing in patients with Duchenne or Becker muscular dystrophy, and we also detail how alternative splicing can serve as a disease modifier in patients by changing the outcome of the primary defect.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28597072     DOI: 10.1007/s00439-017-1820-9

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  159 in total

1.  The human Prp8 protein is a component of both U2- and U12-dependent spliceosomes.

Authors:  H R Luo; G A Moreau; N Levin; M J Moore
Journal:  RNA       Date:  1999-07       Impact factor: 4.942

2.  Trans-acting factors may cause dystrophin splicing misregulation in BMD skeletal muscles.

Authors:  M Sironi; R Cagliani; G P Comi; U Pozzoli; A Bardoni; R Giorda; N Bresolin
Journal:  FEBS Lett       Date:  2003-02-27       Impact factor: 4.124

3.  A novel cryptic exon in intron 3 of the dystrophin gene was incorporated into dystrophin mRNA with a single nucleotide deletion in exon 5.

Authors:  Ryo Suminaga; Yasuhiro Takeshima; Kayo Adachi; Mariko Yagi; Hajime Nakamura; Masafumi Matsuo
Journal:  J Hum Genet       Date:  2002       Impact factor: 3.172

4.  Detecting and characterizing circular RNAs.

Authors:  William R Jeck; Norman E Sharpless
Journal:  Nat Biotechnol       Date:  2014-05       Impact factor: 54.908

5.  A novel splicing silencer generated by DMD exon 45 deletion junction could explain upstream exon 44 skipping that modifies dystrophinopathy.

Authors:  Ery Kus Dwianingsih; Rusdy Ghazali Malueka; Atsushi Nishida; Kyoko Itoh; Tomoko Lee; Mariko Yagi; Kazumoto Iijima; Yasuhiro Takeshima; Masafumi Matsuo
Journal:  J Hum Genet       Date:  2014-05-29       Impact factor: 3.172

6.  An exon skipping-associated nonsense mutation in the dystrophin gene uncovers a complex interplay between multiple antagonistic splicing elements.

Authors:  A Disset; C F Bourgeois; N Benmalek; M Claustres; J Stevenin; Sylvie Tuffery-Giraud
Journal:  Hum Mol Genet       Date:  2006-02-06       Impact factor: 6.150

Review 7.  RNA-Seq: a revolutionary tool for transcriptomics.

Authors:  Zhong Wang; Mark Gerstein; Michael Snyder
Journal:  Nat Rev Genet       Date:  2009-01       Impact factor: 53.242

8.  DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy.

Authors:  Olga L Gurvich; Therese M Tuohy; Michael T Howard; Richard S Finkel; Livija Medne; Christine B Anderson; Robert B Weiss; Steve D Wilton; Kevin M Flanigan
Journal:  Ann Neurol       Date:  2008-01       Impact factor: 10.422

9.  Massive idiosyncratic exon skipping corrects the nonsense mutation in dystrophic mouse muscle and produces functional revertant fibers by clonal expansion.

Authors:  Q L Lu; G E Morris; S D Wilton; T Ly; O V Artem'yeva; P Strong; T A Partridge
Journal:  J Cell Biol       Date:  2000-03-06       Impact factor: 10.539

Review 10.  Duchenne Muscular Dystrophy: From Diagnosis to Therapy.

Authors:  Maria Sofia Falzarano; Chiara Scotton; Chiara Passarelli; Alessandra Ferlini
Journal:  Molecules       Date:  2015-10-07       Impact factor: 4.411

View more
  17 in total

Review 1.  More than a messenger: Alternative splicing as a therapeutic target.

Authors:  A J Black; J R Gamarra; J Giudice
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2019-07-02       Impact factor: 4.490

Review 2.  Duchenne and Becker Muscular Dystrophies: A Review of Animal Models, Clinical End Points, and Biomarker Quantification.

Authors:  Kristin Wilson; Crystal Faelan; Janet C Patterson-Kane; Daniel G Rudmann; Steven A Moore; Diane Frank; Jay Charleston; Jon Tinsley; G David Young; Anthony J Milici
Journal:  Toxicol Pathol       Date:  2017-10-03       Impact factor: 1.902

3.  Functional characterization of ABCC8 variants of unknown significance based on bioinformatics predictions, splicing assays, and protein analyses: Benefits for the accurate diagnosis of congenital hyperinsulinism.

Authors:  Cécile Saint-Martin; Marine Cauchois-Le Mière; Emily Rex; Omar Soukarieh; Jean-Baptiste Arnoux; Julien Buratti; Delphine Bouvet; Thierry Frébourg; Pascaline Gaildrat; Show-Ling Shyng; Christine Bellanné-Chantelot; Alexandra Martins
Journal:  Hum Mutat       Date:  2021-01-28       Impact factor: 4.878

Review 4.  Histopathology of Duchenne muscular dystrophy in correlation with changes in proteomic biomarkers.

Authors:  Margit Zweyer; Hemmen Sabir; Paul Dowling; Stephen Gargan; Sandra Murphy; Dieter Swandulla; Kay Ohlendieck
Journal:  Histol Histopathol       Date:  2021-12-07       Impact factor: 2.303

Review 5.  Alternative Splicing in the Hippo Pathway-Implications for Disease and Potential Therapeutic Targets.

Authors:  Sean Porazinski; Michael Ladomery
Journal:  Genes (Basel)       Date:  2018-03-13       Impact factor: 4.096

6.  Competing Endogenous RNA in Colorectal Cancer: An Analysis for Colon, Rectum, and Rectosigmoid Junction.

Authors:  Lucas Maciel Vieira; Natasha Andressa Nogueira Jorge; João Batista de Sousa; João Carlos Setubal; Peter F Stadler; Maria Emília Machado Telles Walter
Journal:  Front Oncol       Date:  2021-06-10       Impact factor: 6.244

7.  Theragnosis for Duchenne Muscular Dystrophy.

Authors:  Leonela Luce; Micaela Carcione; Chiara Mazzanti; Paula I Buonfiglio; Viviana Dalamón; Lilia Mesa; Alberto Dubrovsky; José Corderí; Florencia Giliberto
Journal:  Front Pharmacol       Date:  2021-06-03       Impact factor: 5.810

8.  Exonization of an Intronic LINE-1 Element Causing Becker Muscular Dystrophy as a Novel Mutational Mechanism in Dystrophin Gene.

Authors:  Ana Gonçalves; Jorge Oliveira; Teresa Coelho; Ricardo Taipa; Manuel Melo-Pires; Mário Sousa; Rosário Santos
Journal:  Genes (Basel)       Date:  2017-10-03       Impact factor: 4.096

Review 9.  The Role of Alternative RNA Splicing in the Regulation of hTERT, Telomerase, and Telomeres: Implications for Cancer Therapeutics.

Authors:  Aaron L Slusher; Jeongjin Jj Kim; Andrew T Ludlow
Journal:  Cancers (Basel)       Date:  2020-06-10       Impact factor: 6.639

10.  A novel DMD intronic alteration: a potentially disease-causing variant of an intermediate muscular dystrophy phenotype.

Authors:  Ricardo Santin; Igor Araujo Vieira; Jean Costa Nunes; Maria Luiza Benevides; Fernanda Quadros; Ana Carolina Brusius-Facchin; Gabriel Macedo; Ana Paula Santin Bertoni
Journal:  Acta Myol       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.